Jaime Schweitzer
Family · Bethel Park, PANPI 1780138560
Payments from drug & device makers
Across 599 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$5K
- Novo Nordisk$1K
- Lilly USA, LLC$406
- Amgen$324
- GSK$319
- Amarin Pharma, Inc.$260
- plus $2K from 32 others
What the payments were for
- Food & beverage$8,969100%
- Education$10%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 293 | $4,720 |
| Novo Nordisk | 94 | $1,151 |
| Lilly USA, LLC | 29 | $406 |
| Amgen | 23 | $324 |
| GSK | 20 | $319 |
| Amarin Pharma, Inc. | 22 | $260 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $201 |
| Takeda Pharmaceuticals U.S.A., Inc. | 10 | $177 |
| E.r. Squibb & Sons, L.L.C. | 8 | $137 |
| Bayer | 14 | $128 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $122 |
| Biohaven Pharmaceuticals, Inc. | 6 | $101 |
| Boehringer Ingelheim | 6 | $92 |
| AstraZeneca | 5 | $82 |
| Merck | 4 | $69 |
| Lundbeck LLC | 3 | $65 |
| Antares Pharma, Inc. | 3 | $52 |
| Axsome Therapeutics, Inc. | 3 | $50 |
| Novartis | 3 | $50 |
| Teva Pharmaceuticals USA, Inc. | 3 | $46 |
| Biogen | 2 | $43 |
| Exact Sciences | 2 | $40 |
| Johnson & Johnson | 2 | $39 |
| Optinose US, Inc. | 2 | $33 |
| Ironwood Pharmaceuticals, Inc | 2 | $33 |
| Supernus Pharmaceuticals, Inc. | 2 | $25 |
| Seqirus USA Inc | 1 | $24 |
| Sunovion Pharmaceuticals Inc. | 1 | $21 |
| Si-bone, Inc. | 1 | $20 |
| Adlon Therapeutics L.p. | 1 | $20 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Alkermes, Inc. | 1 | $16 |
| Astellas Pharma US Inc | 1 | $16 |
| Cranial Technologies, Inc | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Noven Therapeutics, LLC | 1 | $14 |
| Corium, LLC | 1 | $13 |
| Kowa Pharmaceuticals America, Inc. | 1 | $13 |
How this compares
$8,970 in reported general payments places this provider in the 95th percentile of 4,717 family providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 70 | $92,328 |
| EliquisApixaban | 82 | $78,886 |
| MounjaroTirzepatide | 18 | $32,096 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 41 | $28,882 |
| OzempicSemaglutide | 15 | $23,812 |
| TradjentaLinagliptin | 28 | $21,853 |
| XareltoRivaroxaban | 13 | $17,683 |
| Breo ElliptaFluticasone/Vilanterol | 33 | $16,394 |
| TrulicityDulaglutide | 12 | $11,314 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 45 | $9,599 |
| InvokanaCanagliflozin | 13 | $6,075 |
| SymbicortBudesonide/Formoterol Fumarate | 19 | $4,703 |
| Atorvastatin Calcium | 488 | $4,566 |
| Novolog FlexpenInsulin Aspart | 12 | $3,850 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 22 | $3,652 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $92 | $114,18198 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $319 | $45,27574 claims |
| Lilly USA, LLCMounjaro, Trulicity | $406 | $43,41030 claims |
| Novo NordiskOzempic | $1,151 | $23,81215 claims |
| Johnson & JohnsonXarelto, Invokana | $39 | $23,75826 claims |
| AstraZenecaSymbicort | $82 | $4,70319 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 4,717 family providers in Pennsylvania.
Other family in Bethel Park
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.